 NAPLES, Fla., Feb. 9, 2021 PRNewswire -- Enveric Biosciences Inc. NASDAQ: ENVB Enveric or the Company, a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that it has entered into definitive... 